R Lee Seward

Title: R Lee Seward: Innovator in Bioerodible Implants

Introduction

R Lee Seward is a notable inventor based in Watchung, NJ (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of bioerodible implants. His innovative work has led to advancements in controlled release dosage forms that are crucial for medical applications.

Latest Patents

R Lee Seward holds 1 patent for his invention related to bioerodible implants. The patent describes a bioerodible controlled release dosage form that comprises a polymer formed by condensing beneficial agents with hydroxyl functionality of two or more with diketene acetals or divinyl ethers. This innovative formulation is designed to deliver beneficial agents to a biological environment of use, ensuring that a statistically significant portion of the beneficial agent is covalently bonded within the polymer matrix.

Career Highlights

Seward is currently employed at Merck & Company, Inc., a leading global healthcare company. His work at Merck has allowed him to focus on developing innovative solutions that enhance patient care and treatment outcomes. His expertise in polymer chemistry and drug delivery systems has positioned him as a key contributor in his field.

Collaborations

Throughout his career, R Lee Seward has collaborated with esteemed colleagues, including Chung Shih and Gaylen M Zentner. These collaborations have fostered a productive environment for innovation and have led to the advancement of various projects within the biomedical sector.

Conclusion

R Lee Seward's contributions to the field of bioerodible implants exemplify the importance of innovation in healthcare. His work continues to influence the development of effective drug delivery systems that improve patient outcomes.